Tectonic Therapeutic (TECX) Competitors $21.82 -0.57 (-2.52%) As of 10:10 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TECX vs. OCUL, EWTX, CALT, EVO, AMPH, ADPT, IOVA, ARDX, GPCR, and AUPHShould you be buying Tectonic Therapeutic stock or one of its competitors? The main competitors of Tectonic Therapeutic include Ocular Therapeutix (OCUL), Edgewise Therapeutics (EWTX), Calliditas Therapeutics AB (publ) (CALT), Evotec (EVO), Amphastar Pharmaceuticals (AMPH), Adaptive Biotechnologies (ADPT), Iovance Biotherapeutics (IOVA), Ardelyx (ARDX), Structure Therapeutics (GPCR), and Aurinia Pharmaceuticals (AUPH). These companies are all part of the "pharmaceutical products" industry. Tectonic Therapeutic vs. Ocular Therapeutix Edgewise Therapeutics Calliditas Therapeutics AB (publ) Evotec Amphastar Pharmaceuticals Adaptive Biotechnologies Iovance Biotherapeutics Ardelyx Structure Therapeutics Aurinia Pharmaceuticals Ocular Therapeutix (NASDAQ:OCUL) and Tectonic Therapeutic (NASDAQ:TECX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment, community ranking and analyst recommendations. Do analysts recommend OCUL or TECX? Ocular Therapeutix currently has a consensus price target of $16.38, indicating a potential upside of 110.75%. Tectonic Therapeutic has a consensus price target of $72.40, indicating a potential upside of 231.88%. Given Tectonic Therapeutic's stronger consensus rating and higher possible upside, analysts clearly believe Tectonic Therapeutic is more favorable than Ocular Therapeutix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ocular Therapeutix 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89Tectonic Therapeutic 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 Which has more volatility and risk, OCUL or TECX? Ocular Therapeutix has a beta of 1.49, suggesting that its share price is 49% more volatile than the S&P 500. Comparatively, Tectonic Therapeutic has a beta of 2.87, suggesting that its share price is 187% more volatile than the S&P 500. Does the MarketBeat Community prefer OCUL or TECX? Ocular Therapeutix received 432 more outperform votes than Tectonic Therapeutic when rated by MarketBeat users. However, 100.00% of users gave Tectonic Therapeutic an outperform vote while only 70.27% of users gave Ocular Therapeutix an outperform vote. CompanyUnderperformOutperformOcular TherapeutixOutperform Votes44270.27% Underperform Votes18729.73% Tectonic TherapeuticOutperform Votes10100.00% Underperform VotesNo Votes Which has better valuation & earnings, OCUL or TECX? Tectonic Therapeutic has lower revenue, but higher earnings than Ocular Therapeutix. Ocular Therapeutix is trading at a lower price-to-earnings ratio than Tectonic Therapeutic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOcular Therapeutix$63.72M19.39-$80.74M-$1.26-6.17Tectonic TherapeuticN/AN/A$12.16M-$6.53-3.34 Is OCUL or TECX more profitable? Tectonic Therapeutic has a net margin of 0.00% compared to Ocular Therapeutix's net margin of -283.74%. Tectonic Therapeutic's return on equity of -35.53% beat Ocular Therapeutix's return on equity.Company Net Margins Return on Equity Return on Assets Ocular Therapeutix-283.74% -45.18% -30.87% Tectonic Therapeutic N/A -35.53%-31.97% Do institutionals & insiders have more ownership in OCUL or TECX? 59.2% of Ocular Therapeutix shares are held by institutional investors. Comparatively, 62.6% of Tectonic Therapeutic shares are held by institutional investors. 3.5% of Ocular Therapeutix shares are held by insiders. Comparatively, 9.2% of Tectonic Therapeutic shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer OCUL or TECX? In the previous week, Tectonic Therapeutic had 9 more articles in the media than Ocular Therapeutix. MarketBeat recorded 12 mentions for Tectonic Therapeutic and 3 mentions for Ocular Therapeutix. Ocular Therapeutix's average media sentiment score of 0.70 beat Tectonic Therapeutic's score of 0.58 indicating that Ocular Therapeutix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ocular Therapeutix 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tectonic Therapeutic 4 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryTectonic Therapeutic beats Ocular Therapeutix on 12 of the 18 factors compared between the two stocks. Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TECX vs. The Competition Export to ExcelMetricTectonic TherapeuticBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$395.58M$2.90B$5.37B$7.70BDividend YieldN/A1.91%5.44%4.32%P/E Ratio-3.6029.3322.0918.22Price / SalesN/A476.27398.07105.44Price / CashN/A168.6838.2034.62Price / Book10.243.026.704.18Net Income$12.16M-$72.17M$3.20B$247.50M7 Day Performance28.17%9.29%5.27%5.92%1 Month Performance2.80%-6.30%-4.75%-3.62%1 Year PerformanceN/A-19.62%17.44%4.75% Tectonic Therapeutic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TECXTectonic Therapeutic2.7568 of 5 stars$21.82-2.5%$72.40+231.9%N/A$395.58MN/A-3.60120OCULOcular Therapeutix3.4689 of 5 stars$7.57+6.5%$16.38+116.3%+70.1%$1.20B$63.72M-5.73230EWTXEdgewise Therapeutics2.354 of 5 stars$12.33+8.0%$40.38+227.5%-4.4%$1.20BN/A-8.2260Positive NewsCALTCalliditas Therapeutics AB (publ)N/A$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180EVOEvotec1.1066 of 5 stars$3.30+3.8%$5.93+79.8%-19.5%$1.17B$777.05M0.004,200Analyst UpgradeAnalyst RevisionNews CoverageGap UpAMPHAmphastar Pharmaceuticals4.3782 of 5 stars$24.42+1.1%$43.50+78.1%-41.3%$1.16B$731.97M8.141,620Positive NewsADPTAdaptive Biotechnologies3.2858 of 5 stars$7.82-1.5%$9.40+20.2%+203.5%$1.16B$178.96M-7.17790Upcoming EarningsPositive NewsIOVAIovance Biotherapeutics4.2225 of 5 stars$3.41+3.3%$18.56+444.2%-71.3%$1.12B$164.07M-2.29500ARDXArdelyx4.2692 of 5 stars$4.57+2.5%$10.61+132.2%-21.9%$1.09B$333.62M-28.5690Upcoming EarningsNews CoverageGPCRStructure Therapeutics2.4442 of 5 stars$18.95+19.2%$81.29+328.9%-35.1%$1.09BN/A-25.61136Analyst ForecastNews CoverageAUPHAurinia Pharmaceuticals2.5604 of 5 stars$7.73+4.3%$11.50+48.8%+61.0%$1.06B$235.13M-51.53300Upcoming EarningsNews CoveragePositive News Related Companies and Tools Related Companies Ocular Therapeutix Competitors Edgewise Therapeutics Competitors Calliditas Therapeutics AB (publ) Competitors Evotec Competitors Amphastar Pharmaceuticals Competitors Adaptive Biotechnologies Competitors Iovance Biotherapeutics Competitors Ardelyx Competitors Structure Therapeutics Competitors Aurinia Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TECX) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tectonic Therapeutic Please log in to your account or sign up in order to add this asset to your watchlist. Share Tectonic Therapeutic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TECX Stock Free TECX Stock Alerts